Close
Close
ALK mutation related non-small cell lung cancer
9895 views
2.7
2.7 from 10 votes

 

Prof Demetri describes two key presentations from ASCO 2010: the rapid progress made developing a therapy for ALK mutation related non-small cell lung cancer patients and the encouraging results of a phase I study into inflammatory myofibroblastic tumour patients with the ALK mutation. Prof Demitri goes on to discuss his current research into the Hsp90 pathway, kinase inhibitors, cancer profiling and IGF-1 receptor agonists.

by Abidemi Uruejoma
6 views 2 days ago
by Abidemi Uruejoma
3 views 2 days ago
by Abidemi Uruejoma
17 views 1 week ago
by Abidemi Uruejoma
30 views 1 week ago
by Abidemi Uruejoma
28 views 1 week ago
by Abidemi Uruejoma
57 views 1 month ago
by Abidemi Uruejoma
76 views 1 month ago
by Abidemi Uruejoma
73 views 1 month ago
2.7
2.7 from 10 votes
Free Newsletter
Find a Clinical Trial
Trending videos
by Abidemi Uruejoma
29,163 views
by Christine DuBois
23,741 views
by Abidemi Uruejoma
21,569 views
News Articles